Henry Scott may refer to: (wikipedia)
It's the best possible win for the case, but it is not the end of the battle. The next test case will really be long-term users. Investor sentiment certainly swings probably more than it should on each individual case.
I think this could be a $1 billion-a-year-drug and is the kind of product Pfizer needs.
We have scout teams who go out and ID where the birds are. And when we find birds using a field, we'll hunt that field.
The question is how large is that market.
I still believe Pfizer will win the U.S. case, but you can never make any assumptions in a patent dispute.
This approval takes some risk out of the equation for them. If they can get the production capacity, it has the potential to be a significant drug. The big issue for Bristol is patent expirations and whether the pipeline can offset them.
Investors will look at the quarter and like fact that they beat estimates.
We have a lot of quail here, and we're going to have quail hunting this fall. It's not uncommon to flush 35 to 40 coveys a day.
We expected higher research and development costs, but the revenues were also on the weak side.
It was mediocre. I thought we'd see more, but they flew fairly well. We'll get on a better field this afternoon.